Location: | London, Hybrid |
---|---|
Salary: | £39,065 to £45,622 per annum (pro-rata), inclusive of London Allowance. |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 2nd January 2025 |
---|---|
Closes: | 16th January 2025 |
Job Ref: | 4679 |
About the Role
This post is funded by a new Knowledge Transfer Partnership (KTP) grant by Innovate UK awarded to researchers at Queen Mary University of London (QMUL) and LIfT BioSciences. The information generated from this exciting project will be instrumental in supporting LIfT BioSciences to improve their cell therapy based on the use of neutrophil-based cell therapies in patients with solid tumours.
This is a hybrid working role based at the LIfT BioSciences facility in London and in the research laboratory of Dr Luigi Ombrato (Barts Cancer Institute). The role offers an exciting opportunity to work as part of a team with LIfT BioSciences and QMUL to develop the knowledge that will underpin the company's future developments with good prospects for career development in the LIfT BioSciences team.
About You
You will be responsible for the development of the innovative 3D co-culture systems and for the optimisation of platforms to study neutrophil cytotoxicity in solid tumours. To deliver this project successfully, it is essential to have a strong scientific and technical background in cell biology and immunology. Experience in tissue culture, flow cytometry and deciphering molecular mechanisms of action is essential. A demonstrated ability to communicate effectively with a range of different individuals is essential to the post. Strong organisation skill and being able to maintain good laboratory records are also essential. An appropriate publication record, with first author publications, would be desirable.
About the Project
This project will focus on the establishment of 3D tumoroid models to re-create the tumour microenvironment (TME) of different cancers, including pancreatic, breast and lung cancer. These models will be used to study the role of neutrophils in the TME to understand how neutrophil cytotoxicity towards cancer cells can be enhanced.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.
The post is based at the Charterhouse Square Campus in London. It is a full-time fixed term appointment for 8 months, with an expected start date of 28th February 2025. The starting salary will be Grade 4, in the range of £39,065 - £45,622 per annum (pro-rata), inclusive of London Allowance.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
Type / Role:
Subject Area(s):
Location(s):